Mycenax Biotech Market Cap

Mycenax Biotech has a market cap or net worth of 9.37 billion as of February 21, 2025. Its market cap has increased by 22.01% in one year.

Market Cap

9.37B

Enterprise Value

9.88B

Revenue

672.85M

Ranking

n/a

PE Ratio

n/a

Stock Price

45.35

Market Cap Chart

Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 9.37B, an increase of 1,504.17%. That is a compound annual growth rate of 18.54%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	9.37B	4.49%
Dec 31, 2024	8.97B	22.00%
Dec 29, 2023	7.35B	-4.53%
Dec 30, 2022	7.70B	32.48%
Dec 30, 2021	5.81B	40.74%
Dec 31, 2020	4.13B	38.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	209.72B
Caliway Biopharmaceuticals	142.08B
Bora Pharmaceuticals Co., LTD.	89.70B
Lotus Pharmaceutical	71.92B
Lumosa Therapeutics	39.86B
Oneness Biotech	38.77B
Polaris Group	36.08B
Pegavision	30.30B

Market Cap Rankings